| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |